Home » Reports » Broker Ratings » AstraZeneca plc 7.8% Potential Upside Indicated by Deutsche Bank
broker ratings

AstraZeneca plc 7.8% Potential Upside Indicated by Deutsche Bank

AstraZeneca plc with EPIC/TICKER (LON:AZN) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ this morning by analysts at Deutsche Bank. AstraZeneca plc are listed in the Health Care sector within UK Main Market. Deutsche Bank have set a target price of 5700 GBX on its stock. This is indicating the analyst believes there is a potential upside of 7.8% from the opening price of 5289 GBX. Over the last 30 and 90 trading days the company share price has increased 34 points and increased 389.5 points respectively. The 1 year high share price is 5505 GBX while the 52 week low is 3680 GBX.

AstraZeneca plc has a 50 day moving average of 5,061.22 GBX and the 200 Day Moving Average price is recorded at 4,793.86. There are currently 1,265,456,559 shares in issue with the average daily volume traded being 2,237,729. Market capitalisation for LON:AZN is £66,816,106,315 GBP.

You might also find these articles of interest:

Register here to be notified of future articles like this
Get all our broker ratings on Twitter as they are published!